Tekla Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $497K | Hold |
66,211
| – | – | 0.02% | 143 |
|
|
2023
Q1 | $299K | Hold |
66,211
| – | – | 0.01% | 159 |
|
|
2022
Q4 | $746K | Hold |
66,211
| – | – | 0.03% | 137 |
|
|
2022
Q3 | $634K | Hold |
66,211
| – | – | 0.03% | 141 |
|
|
2022
Q2 | $536K | Hold |
66,211
| – | – | 0.02% | 150 |
|
|
2022
Q1 | $1.12M | Hold |
66,211
| – | – | 0.04% | 144 |
|
|
2021
Q4 | $1.42M | Buy |
66,211
+59,112
| +833% | +$1.27M | 0.05% | 137 |
|
|
2021
Q3 | $524K | Buy |
+7,099
| New | +$524K | 0.02% | 162 |
|